Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · Real-Time Price · USD

29.71

+0.67 (2.31%)

At close: Nov 3, 2026, 4:00 PM EST

30.00

+0.29 (0.98%)

Pre-market: Nov 4, 2026, 7:48 AM EST

Celldex Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,333	1,805	1,677	2,169	2,099	1,803
Market Cap Growth	31.44%	7.65%	-22.71%	3.32%	16.42%	160.10%
Enterprise Value	1,620	1,224	924	1,936	1,779	1,383
Last Close Price	29.71	27.16	25.27	39.66	44.57	38.64

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	14766.53	1168.13	238.82	315.12	890.64	387.68
PB Ratio	3.26	3.42	2.24	5.05	6.44	4.30
P/TBV Ratio	3.39	3.61	2.33	5.40	7.02	4.60

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	10255.88	792.34	131.57	281.34	754.94	297.37

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.00	0.01	0.01	0.01	0.01
Net Debt / Equity Ratio	-1.00	-0.98	-0.97	-0.98	-0.92	-0.97
Net Debt / EBITDA Ratio	2.21	1.82	3.76	3.03	2.89	6.13
Net Debt / FCF Ratio	2.94	2.42	4.52	3.86	2.85	6.52
Asset Turnover	0	0.00	0.01	0.02	0.01	0.01
Quick Ratio	11.71	10.21	18.38	13.69	16.41	24.71
Current Ratio	11.82	10.49	18.92	13.87	17.07	24.86
Return on Equity (ROE)	-43.88%	-40.62%	-26.84%	-37.45%	-30.13%	-22.43%
Return on Assets (ROA)	-27.62%	-26.12%	-19.38%	-21.70%	-16.79%	-12.70%
Return on Capital Employed (ROCE)	-45.20%	-54.00%	-25.90%	-32.70%	-32.10%	-16.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-14.59%	-14.34%	-9.42%	-6.52%	-5.35%	-3.91%
FCF Yield	-10.38%	-11.84%	-9.53%	-5.03%	-5.03%	-3.45%
Buyback Yield / Dilution	-4.49%	-3.15%	-32.91%	-3.33%	-9.37%	-44.64%

SEC Filings: 10-K · 10-Q